Enterra Medical

Executive Summary

Enterra Medical is a private medical device company dedicated to advancing the treatment of chronic gastroparesis through its Enterra Therapy, a surgically implanted neurostimulation system. The therapy is FDA-approved for patients who fail to respond to medical management, providing significant symptom relief. With a focused mission to improve patient outcomes and expand access, the company continues to invest in technology enhancements and clinical evidence generation. Enterra Medical benefits from a clear unmet need in the gastroenterology space, where treatment options for gastroparesis are limited. The company's strategy centers on physician education, patient awareness, and reimbursement optimization to drive adoption. While the market is niche, the strong clinical profile of Enterra Therapy and the company's singular focus position it for steady growth.

Upcoming Catalysts (preview)

• Q3 2026FDA approval for next-generation implantable neurostimulator70% success
• Q4 2026Positive 1-year outcomes from prospective registry study75% success
• H2 2026Strategic distribution partnership with major GI device company55% success